BB Biotech AG (BIONn)

Currency in EUR
57.000
+1.200(+2.15%)
Delayed Data·
Trading near 52-week High
High dividend Yield
BIONn is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
56.10057.400
52 wk Range
32.60057.400
Key Statistics
Bid/Ask
56.90 / 57.30
Prev. Close
55.8
Open
56.1
Day's Range
56.1-57.4
52 wk Range
32.6-57.4
Volume
3.93K
Average Volume (3m)
8.96K
1-Year Change
60.1124%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIONn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

BB Biotech AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

BB Biotech AG Earnings Call Summary for Q2/2026

  • BB Biotech's portfolio outperformed the biotech sector index in Q2 2025, led by Revolution Medicines, Oruka, and Relay Therapeutics gains.
  • Investment pace accelerated to 10+ new positions per quarter versus one to two historically as firm transitions to AI-driven operating model.
  • Company expects to complete proprietary AI operating system in 2025, integrating all investment and research functions into unified platform.
  • Stock rose 1.5% to $54.3, trading near 52-week high of $56.3; management cited biotech sector re-acceleration after Q1 pause.
  • Eight portfolio acquisitions in past two years represent 20% of all deals in firm's 32-year history; no EPS or revenue guidance provided.
Last Updated: 2026-07-24, 07:42 a/m
Read Full Transcript

Earnings

Latest Release
Jul 27, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 24.49%
Dividend Yield
4.42%
Industry Median 1.87%
Annualized payout
2.47
Paid annually
5-Years Growth
-8.97%
Growth Streak

BIONn Income Statement

Compare BIONn to Peers and Sector

Metrics to compare
BIONn
Peers
Sector
Relationship
P/E Ratio
2.1x13.9x10.0x
PEG Ratio
0.010.250.03
Price/Book
0.9x0.6x1.0x
Price / LTM Sales
2.1x1.5x2.9x
Upside (Analyst Target)
11.1%26.6%13.9%
Fair Value Upside
Unlock7.1%2.8%Unlock

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.36M6.09%187.42M
Other Institutional Investors
3.17M5.74%176.68M
Public Companies & Retail Investors
48.62M88.17%2.71B
Total
55.15M100.00%3.08B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
UBS Asset Management AG5.06%2,788,876155,619
Saba Capital Management, L.P.2.86%1,579,39088,130

People Also Watch

114.800
TLXGn
0.00%
58.600
NEKG
+1.03%
83.850
AOFG
-2.04%
57.80
ADNGk
-0.52%
83.450
HYQGn
-0.36%

FAQ

What Is the BB Biotech (BIONn) Stock Price Today?

The BB Biotech stock price today is 57.000 EUR.

What Stock Exchange Does BB Biotech Trade On?

BB Biotech is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for BB Biotech?

The stock symbol for BB Biotech is "BIONn."

Does BB Biotech Pay Dividends? What’s The Current Dividend Yield?

The BB Biotech dividend yield is 4.42%.

What Is the BB Biotech Market Cap?

As of today, BB Biotech market cap is 3.160B EUR.

What Is BB Biotech's Earnings Per Share (TTM)?

The BB Biotech EPS (TTM) is 24.494.

When Is the Next BB Biotech Earnings Date?

BB Biotech will release its next earnings report on Oct 23, 2026.

From a Technical Analysis Perspective, Is BIONn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has BB Biotech Stock Split?

BB Biotech has split 2 times.

How Many Employees Does BB Biotech Have?

BB Biotech has 10 employees.

What is the current trading status of BB Biotech (BIONn)?

As of Jul 31, 2026, BB Biotech (BIONn) is trading at a price of 57.000 EUR, with a previous close of 55.800 EUR. The stock has fluctuated within a day range of 56.100 EUR to 57.400 EUR, while its 52-week range spans from 32.600 EUR to 57.400 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.